Molecular impact of MinK on the enantiospecific block of IKs by chromanols

Slowly activating IKs (KCNQ1/MinK) channels were expressed in Xenopous oocytes and their sensitivity to chromanols was compared to homomeric KCNQ1 channels. To elucidate the contribution of the β‐subunit MinK on chromanol block, a formerly described chromanol HMR 1556 and its enantiomer S5557 were tested for enantio‐specificity in blocking IKs and KCNQ1 as shown for the single enantiomers of chromanol 293B. Both enantiomers blocked homomeric KCNQ1 channels to a lesser extent than heteromeric IKs channels. Furthermore, we expressed both WT and mutant MinK subunits to examine the involvement of particular MinK protein regions in channel block by chromanols. Through a broad variety of MinK deletion and point mutants, we could not identify amino acids or regions where sensitivity was abolished or strikingly diminished (>2.5 fold). This could indicate that MinK does not directly take part in chromanol binding but acts allosterically to facilitate drug binding to the principal subunit KCNQ1.

[1]  M. Sanguinetti,et al.  Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. , 1991, Circulation research.

[2]  A. Schömig,et al.  Differential Effect of β‐Adrenergic Stimulation on the Frequency‐Dependent Electrophysiologic Actions of the New Class III Antiarrhythmics Dofetilide, Ambasilide, and Chromanol 293. , 1997 .

[3]  W. Stühmer,et al.  The role of the IsK protein in the specific pharmacological properties of the IKs channel complex , 1997, British journal of pharmacology.

[4]  M. Sanguinetti.  Dysfunction of Delayed Rectifier Potassium Channels in an Inherited Cardiac Arrhythmia , 1999, Annals of the New York Academy of Sciences.

[5]  G. Landes,et al.  Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[6]  H. Duff,et al.  Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites. , 2000, Molecular pharmacology.

[7]  S. Goldstein,et al.  The conduction pore of a cardiac potassium channel , 1998, Nature.

[8]  B. Attali,et al.  Stilbenes and fenamates rescue the loss of IKS channel function induced by an LQT5 mutation and other IsK mutants , 1999, The EMBO journal.

[9]  Jacques Barhanin,et al.  KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.

[10]  S. Nakanishi,et al.  Cloning of a membrane protein that induces a slow voltage-gated potassium current. , 1988, Science.

[11]  A. Busch,et al.  The IKs channel: coassembly of IsK (minK) and KvLQT1 proteins. , 1999, Reviews of physiology, biochemistry and pharmacology.

[12]  A. Wei,et al.  Molecular Cloning and Functional Expression of KCNQ5, a Potassium Channel Subunit That May Contribute to Neuronal M-current Diversity* , 2000, The Journal of Biological Chemistry.

[13]  Andrea Brüggemann,et al.  Inhibition of IKs channels by HMR 1556 , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[14]  M. Rizzo,et al.  Specific blockade of slowly activating IsK channels by chromanols — impact on the role of IsK channels in epithelia , 1996, FEBS letters.

[15]  D. Escande,et al.  KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl- chromane. , 1997, Molecular pharmacology.

[16]  S. Nakanishi,et al.  Alteration of channel activities and gating by mutations of slow ISK potassium channel. , 1991, The Journal of biological chemistry.

[17]  F. Conti,et al.  Activation and inactivation of homomeric KvLQT1 potassium channels. , 1998, Biophysical journal.

[18]  M. Sanguinetti,et al.  Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. , 1996, Nature.